abstract |
The subject of the present invention is compounds activating the CFTR channel, belonging to the family of benzo [c] quinoliziniums, or to families of compounds derived from the latter, as well as the pharmaceutical compositions containing these compounds, and their uses, in particular in as part of the treatment for cystic fibrosis. |